SELLAS Life Sciences Group Inc. Common Stock vs Sasol Ltd. American Depositary Shares — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B), while Sasol Ltd. American Depositary Shares trades at $15.05 (market cap $9.25B). The key difference: Sasol Ltd. American Depositary Shares is far larger — about 4.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Sasol Ltd. American Depositary Shares is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | SSL | |
|---|---|---|
Market Cap | $2.28B | $9.25B |
Volume | 3,128,960 | 1,222,173 |
Sector | Health | Basic Materials |
52-Week High | $15.46 | $15.14 |
52-Week Low | $1.39 | $5.33 |
Enterprise Value | $2.15B | $12.97B |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →